Evidence map›Paper›PMID 34215750›Full record

ArticleNature communications2021

Redirected nuclear glutamate dehydrogenase supplies Tet3 with α-ketoglutarate in neurons.

Franziska R Traube, Dilara Özdemir, Hanife Sahin, Constanze Scheel, Andrea F Glück, Anna S Geserich, Sabine Oganesian, Sarantos Kostidis, Katharina Iwan, René Rahimoff and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Toward targeted therapeutics for lobular breast cancer.The Journal of clinical investigation · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Franziska R TraubeDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-5691-1941
Dilara ÖzdemirDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Hanife SahinDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Constanze ScheelDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Andrea F GlückDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Anna S GeserichDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Sabine OganesianDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Sarantos KostidisLeiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands.ORCID 0000-0002-2040-2563
Katharina IwanDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-5223-0620
René RahimoffDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Grazia GiorgioDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Markus MüllerDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-3579-3317
Fabio SpadaDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-7148-9013
Martin BielDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Jürgen CoxComputational Systems Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0001-8597-205X
Martin GieraLeiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands.ORCID 0000-0003-1684-1894
Stylianos MichalakisDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany. michalakis@lmu.de.ORCID 0000-0001-5092-9238
Thomas CarellDepartment of Chemistry, Ludwig-Maximilians-Universität München, Munich, Germany. thomas.carell@lmu.de.ORCID 0000-0001-7898-2831
Ludwig-Maximilians-Universität München · DELeiden University Medical Center · NLLMU Klinikum · DEMax Planck Institute of Biochemistry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tet3 is the main α-ketoglutarate (αKG)-dependent dioxygenase in neurons that converts 5-methyl-dC into 5-hydroxymethyl-dC and further on to 5-formyl- and 5-carboxy-dC. Neurons possess high levels of 5-hydroxymethyl-dC that further increase during neural activity to establish transcriptional plasticity required for learning and memory functions. How αKG, which is mainly generated in mitochondria as an intermediate of the tricarboxylic acid cycle, is made available in the nucleus has remained an unresolved question in the connection between metabolism and epigenetics. We show that in neurons the mitochondrial enzyme glutamate dehydrogenase, which converts glutamate into αKG in an NAD

Indexed as

AnimalsBrainCell NucleusCitric Acid CycleDioxygenasesEpigenomicsGene ExpressionGlutamate DehydrogenaseGlutamic AcidHEK293 CellsHumansKetoglutarate Dehydrogenase ComplexKetoglutaric AcidsMetabolomicsMiceMice, Inbred C57BLDioxygenasesGlutamate DehydrogenaseGlutamic AcidKetoglutarate Dehydrogenase ComplexKetoglutaric AcidsTET3 protein, humanTet3 protein, mouse

Identifiers

PMID34215750
PMCPMC8253819
OpenAlexW3173436154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.